Microaneurysm: Clinical Trials

4 trials for Microaneurysm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 1 Early Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 11Not yet recruiting 1
Phase 21Completed 1
Phase 41Completed 1

Follow Microaneurysm: new trials by email Literature Review of Microaneurysm trials Research Report on Microaneurysm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy
Investigational Eye Drops (NPDR-01) - Non-proliferative Diabetic Retinopathy (NPDR), Diabetic Retinal Microangiopathy
Early Phase 1Not yet recruitingSichuan Academy of Medical Sciences102025-12-012025-09-30
Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy
Lucentis - Nonproliferative Diabetic Retinopathy
Phase 4CompletedWonkwang University Hospital252016-08-012020-05-22
Computer-based Screening for Diabetic Retinopathy
Diabetic Retinopathy
CompletedVisionQuest Biomedical LLC191992012-08-012017-09-18
Diabetic Retinopathy Sulodexide Study
sulodexide - Diabetic Retinopathy
Phase 2CompletedAjou University School of Medicine1272009-02-012012-11-06

Narrower conditions

Diabetic Retinopathy (3)  ·  Hemorrhage (1)  ·  Neovascularization, Pathologic (1)  ·  Prediabetic State (1)

Broader conditions

Aneurysm (4)  ·  Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Diabetes Complications (3)  ·  Diabetes Mellitus (3)  ·  Diabetic Angiopathies (3)  ·  Endocrine System Diseases (3)  ·  Eye Diseases (3)  ·  Retinal Diseases (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Metaplasia (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Ranibizumab (1)  ·  glucuronyl glucosamine glycan sulfate (1)

Sponsors

Ajou University School of Medicine (1)  ·  Sichuan Academy of Medical Sciences (1)  ·  VisionQuest Biomedical LLC (1)  ·  Wonkwang University Hospital (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Gilberto Zamora, PhD (1)  ·  Ha Kyoung Kim, MD (1)  ·  Seungjoon Lee, MD, Ph D (1)  ·  Yunsik Yang, MD, Ph D (1)

Results publications

PMID 25112845

NIH funding

R44EY018280 (1)